99 related articles for article (PubMed ID: 15516756)
1. Synthesis and pharmacological evaluation of novel arylpiperazine derivatives as nonsteroidal androgen receptor antagonists.
Kinoyama I; Taniguchi N; Yoden T; Koutoku H; Furutani T; Kudoh M; Okada M
Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1330-3. PubMed ID: 15516756
[TBL] [Abstract][Full Text] [Related]
2. N-Arylpiperazine-1-carboxamide derivatives: a novel series of orally active nonsteroidal androgen receptor antagonists.
Kinoyama I; Taniguchi N; Kawaminami E; Nozawa E; Koutoku H; Furutani T; Kudoh M; Okada M
Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):402-9. PubMed ID: 15802840
[TBL] [Abstract][Full Text] [Related]
3. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
Chen H; Yu YZ; Tian XM; Wang CL; Qian YN; Deng ZA; Zhang JX; Lv DJ; Zhang HB; Shen JL; Yuan M; Zhao SC
Bioorg Med Chem; 2019 Jan; 27(1):133-143. PubMed ID: 30482547
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 7alpha-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure-activity relationships.
Tachibana K; Imaoka I; Yoshino H; Emura T; Kodama H; Furuta Y; Kato N; Nakamura M; Ohta M; Taniguchi K; Ishikura N; Nagamuta M; Onuma E; Sato H
Bioorg Med Chem; 2007 Jan; 15(1):174-85. PubMed ID: 17064916
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of naftopidil-based arylpiperazine derivatives containing the bromophenol moiety.
Chen H; Qian Y; Jia H; Yu Y; Zhang H; Shen J; Zhao S
Pharmacol Rep; 2020 Aug; 72(4):1058-1068. PubMed ID: 32048266
[TBL] [Abstract][Full Text] [Related]
7. Preparation of piperazine derivatives as 5-HT7 receptor antagonists.
Yoon J; Yoo EA; Kim JY; Pae AN; Rhim H; Park WK; Kong JY; Park Choo HY
Bioorg Med Chem; 2008 May; 16(10):5405-12. PubMed ID: 18456500
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric synthesis and biological evaluation of N-cyclohexyl-4-[1-(2,4-dichlorophenyl)-1-(p-tolyl)methyl]piperazine-1-carboxamide as hCB1 receptor antagonists.
Gao L; Li M; Meng T; Peng H; Xie X; Zhang Y; Jin Y; Wang X; Zou L; Shen J
Eur J Med Chem; 2011 Nov; 46(11):5310-6. PubMed ID: 21937154
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel androgen receptor antagonists using structure- and ligand-based methods.
Li H; Ren X; Leblanc E; Frewin K; Rennie PS; Cherkasov A
J Chem Inf Model; 2013 Jan; 53(1):123-30. PubMed ID: 23278403
[TBL] [Abstract][Full Text] [Related]
10. Discovery of an orally-active nonsteroidal androgen receptor pure antagonist and the structure-activity relationships of its derivatives.
Tachibana K; Imaoka I; Shiraishi T; Yoshino H; Nakamura M; Ohta M; Kawata H; Taniguchi K; Ishikura N; Tsunenari T; Saito H; Nagamuta M; Nakagawa T; Takanashi K; Onuma E; Sato H
Chem Pharm Bull (Tokyo); 2008 Nov; 56(11):1555-61. PubMed ID: 18981605
[TBL] [Abstract][Full Text] [Related]
11. Using the protein chip to screen agonists and antagonists of the androgen receptor.
Zhou Y; Liu A; Wang W; Du G
J Biomol Screen; 2008 Apr; 13(4):276-84. PubMed ID: 18349422
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.
Jin J; Wang XB; Kong LY
Bioorg Med Chem Lett; 2011 Feb; 21(3):909-11. PubMed ID: 21236664
[TBL] [Abstract][Full Text] [Related]
13. CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives.
Imamura S; Ishihara Y; Hattori T; Kurasawa O; Matsushita Y; Sugihara Y; Kanzaki N; Iizawa Y; Baba M; Hashiguchi S
Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):63-73. PubMed ID: 14709870
[TBL] [Abstract][Full Text] [Related]
14. Steroid derivatives as pure antagonists of the androgen receptor.
Gauthier S; Martel C; Labrie F
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):93-104. PubMed ID: 22449547
[TBL] [Abstract][Full Text] [Related]
15. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
Kawata H; Arai S; Nakagawa T; Ishikura N; Nishimoto A; Yoshino H; Shiraishi T; Tachibana K; Nakamura R; Sato H
Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of 3-aryl-3-hydroxy-1-phenylpyrrolidine derivatives as novel androgen receptor antagonists.
Yamamoto S; Kobayashi H; Kaku T; Aikawa K; Hara T; Yamaoka M; Kanzaki N; Hasuoka A; Baba A; Ito M
Bioorg Med Chem; 2013 Jan; 21(1):70-83. PubMed ID: 23199477
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 4,5-diphenyl-1,2,4-triazole derivatives as a novel class of selective antagonists for the human V(1A) receptor.
Kakefuda A; Suzuki T; Tobe T; Tahara A; Sakamoto S; Tsukamoto Si
Bioorg Med Chem; 2002 Jun; 10(6):1905-12. PubMed ID: 11937348
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists.
Ivachtchenko AV; Ivanenkov YA; Mitkin OD; Vorobiev AA; Kuznetsova IV; Shevkun NA; Koryakova AG; Karapetian RN; Trifelenkov AS; Kravchenko DV; Veselov MS; Chufarova NV
Eur J Med Chem; 2015 Jun; 99():51-66. PubMed ID: 26046313
[TBL] [Abstract][Full Text] [Related]
19. Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
Di Fabio R; Griffante C; Alvaro G; Pentassuglia G; Pizzi DA; Donati D; Rossi T; Guercio G; Mattioli M; Cimarosti Z; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
J Med Chem; 2009 May; 52(10):3238-47. PubMed ID: 19388677
[TBL] [Abstract][Full Text] [Related]
20. Piperazinyl oxime ethers as NK-1 receptor antagonists.
van den Hoogenband A; van Maarseveen JH; McCreary AC; Mulder AT; van Scharrenburg GJ; van Stuivenberg HH; Zethof TJ; Zijta B; Iwema Bakker WI
Bioorg Med Chem Lett; 2006 Feb; 16(4):1045-8. PubMed ID: 16289817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
